When Should I Discharge a Patient for Non-Compliance.

Patient discharge from a controlled substance prescribing relationship should occur when the clinical and compliance indicators establish that continued prescribing no longer serves a legitimate therapeutic purpose or that it creates unacceptable risks of diversion or harm that the monitoring framework cannot adequately manage.

The decision to discharge a patient from a controlled substance prescribing relationship is a clinical decision with legal and ethical dimensions that require careful management. It is not primarily a punitive action; it is a clinical determination that the prescribing relationship has reached a point where continuation is clinically inappropriate. The documentation of that determination, and the manner in which the discharge is communicated and implemented, determines whether the decision is defensible.

Specific Grounds for Discharge

The controlled substance agreement that patients sign at the initiation of therapy typically identifies the grounds on which prescribing will be discontinued. The most common grounds include: a urine drug screen positive for illicit substances, indicating concurrent non-medical drug use that is inconsistent with the therapeutic goals of the prescribing relationship; a urine drug screen negative for prescribed medications, indicating that the medications are not being consumed therapeutically and may be diverted; obtaining controlled substances from another prescriber without disclosure, in violation of the single-prescriber requirement; selling or sharing prescribed medications; providing false information about medical history or medication use to obtain prescriptions; or repeated failure to comply with monitoring requirements.

Each ground should be documented with clinical specificity: the specific finding that was identified, the date it was identified, the discussion with the patient about the finding, and the clinical determination reached. The discharge decision that follows documented compliance failures over a period of time is more clinically defensible than the discharge that occurs after a single incident, and more clinically defensible than the discharge that occurs without any documented patient discussion.

The Process of Discharge

Discharging a patient from a controlled substance prescribing relationship requires a process that respects the patient's right to continued medical care and that does not constitute patient abandonment. The discharge should be communicated to the patient in writing, should identify the clinical grounds for the discharge, should provide a reasonable transition period during which the patient can establish care with another provider, and should offer referral to appropriate addiction treatment if the clinical circumstances suggest that the patient would benefit from such services.

The transition period is typically thirty days for non-urgent situations, during which the practitioner may provide bridge prescriptions of sufficient duration to permit the patient to establish care with another provider. In emergency situations involving imminent risk of harm, the transition period may be shortened. In all cases, the practitioner should document the discharge communication, the transition provisions offered, and the patient's response.

The Clinical Record of the Discharge Decision

The discharge decision should be documented in the patient's medical record with the same clinical specificity as any other significant clinical decision. The record should identify the compliance failures or clinical indicators that prompted the discharge, the timeline of those failures, the discussions with the patient about compliance expectations and the consequences of non-compliance, and the clinical rationale for the decision that continued prescribing was no longer appropriate.

A discharge decision that is documented with this specificity is a clinical decision with a clear evidentiary foundation. It demonstrates that the practitioner applied clinical judgment to the prescribing relationship and acted on that judgment when the clinical situation warranted action. In the context of a DEA investigation, documented patient discharges for non-compliance are evidence that the practitioner maintained clinical standards and enforced them, which is among the most compelling evidence available that the prescribing practice was clinically managed rather than commercially motivated.

The practitioner who discharged twenty patients over five years for documented compliance failures has twenty records of clinical judgment that serve the defense. Each discharge record tells the same story: that the practitioner was monitoring, that they identified a compliance failure, that they addressed it with the patient, and that they made a clinical decision based on the finding. That story, repeated twenty times across five years, is not the story of a commercial drug distribution operation.

Avoiding Discriminatory Discharge

Discharge decisions should be made consistently across the patient population, based on documented clinical and compliance grounds rather than on patient characteristics unrelated to clinical care. A practice that discharges patients for compliance failures when those failures are documented, regardless of the patient's demographics, insurance status, or other personal characteristics, has a discharge record that reflects clinical consistency. A practice whose discharge records suggest that certain categories of patients were discharged for reasons that are not documented in clinical terms has created a discrimination exposure alongside the compliance exposure. The documentation standard that protects against the latter also protects against the former.